Premium
Association of Epicardial Adipose Tissue With Cardiometabolic Risk and Metabolic Syndrome in Patients With Rheumatoid Arthritis
Author(s) -
Ormseth Michelle J.,
Lipson Aliza,
Alexopoulos Nikolaos,
Hartlage Gregory R.,
Oeser Annette M.,
Bian Aihua,
Gebretsadik Tebeb,
Shintani Ayumi,
Raggi Paolo,
Stein C. Michael
Publication year - 2013
Publication title -
arthritis care and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.032
H-Index - 163
eISSN - 2151-4658
pISSN - 2151-464X
DOI - 10.1002/acr.22027
Subject(s) - medicine , insulin resistance , metabolic syndrome , rheumatoid arthritis , endocrinology , waist , adipose tissue , obesity , diabetes mellitus , cardiology , homeostatic model assessment
Objective Patients with rheumatoid arthritis (RA) have increased coronary atherosclerosis possibly related to increased prevalence of visceral adiposity, insulin resistance, and metabolic syndrome. Epicardial adipose tissue (EAT), a type of visceral fat, may contribute to cardiometabolic risk. The aim of this study was to measure EAT volume in patients with RA and determine its relationship with cardiometabolic risk markers and coronary artery calcium. Methods EAT volume and coronary artery calcium score were measured by noncontrast cardiac computed tomography and compared in RA patients (n = 162) and controls (n = 89). The relationships between EAT volume and markers of cardiometabolic risk in RA were examined with adjustment for age, race, and sex. Results Among RA patients, EAT volume was positively associated with interleukin‐6 ( P = 0.03), triglycerides ( P = 0.004), hypertension ( P = 0.01), homeostatic model of insulin resistance (HOMA) ( P < 0.001), smoking history ( P = 0.04), and homocysteine level ( P = 0.001), and negatively associated with high‐density lipoprotein ( P = 0.005). With further adjustment for waist circumference (a measure of visceral obesity), EAT volume remained independently associated with triglycerides, HOMA, current smoking, and homocysteine level (all P < 0.05). EAT volume was not associated with corticosteroid use or coronary artery calcium score. Patients with metabolic syndrome had significantly greater EAT volume ( P < 0.001) and each increase in metabolic syndrome criteria was associated, on average, with a 20% increase (95% confidence interval 14–26%) in EAT volume ( P < 0.001). Conclusion EAT volume is associated with metabolic syndrome and cardiometabolic risk factors, including insulin resistance, triglycerides, current smoking, and homocysteine levels, but not with coronary artery calcium in RA patients.